Pharmaceuticals

Coya Therapeutics receives $5 million investment from Alzheimer’s Disease Drug Discovery Foundation

bexib
By bexib 0 Min Read

The investment from the Alzheimer’s Disease Drug Discovery Foundation (ADDF) is aimed at supporting the development of Coya 302, a potential treatment for frontotemporal dementia (FTD).

You Might Also Like

How the Pharma Industry Can Survive the Tik Tok Ban: A Q&A with Justin Chase

Women’s Health Care: Will changes to the law stifle the latest innovations in fertility and contraceptive treatments?

NHS to roll out fiber optic laser treatment to prevent seizures in epilepsy patients

US researchers develop AI liquid biopsy test to help detect lung cancer early

UK dementia organisations launch new manifesto ahead of general election

Share This Article
Previous Article How To Make and Sell Merch Your Fans Will Love (2024)
Next Article Avian influenza found in cows on U.S. dairy farms in Kansas and Texas – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

China’s seapower expands as US shipyards decline
Manufacturing
Print advertising is an e-commerce opportunity
Retail & E-commerce
Top 6 banking trends to grow across Asia in 2025
Fintech
The Difference Between Direct Carrier Appointments and Producer Sub-Codes
Insurance